ÂÜÀòÂÒÂ×

Carlos Escande's work experience includes serving as a Principal Investigator at the Institut Pasteur de Montevideo and currently holding the position of Chief Scientific Officer at EOLO PHARMA since January 2016.

Carlos Escande's education history reveals that they obtained a Licenciatura degree in Biología/Ciencias biológicas, general from Universidad de la República, which they pursued from 1997 to 2004. Subsequently, they pursued a Doctorado in the same field of study at the same university from 2007 to 2010. After completing their Doctorate, Carlos pursued a Posdoctorado at the Mayo Clinic Alix School of Medicine from 2010 to 2013, specializing in Fisiología molecular.